(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate

医药中间体 · — · —

医药中间体Confidentiality：公开

INN / Generic Name: (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
Dosage Form: —
Strength: —
Therapy Area: Pharmaceutical Intermediates
Indication: API: Ixazomib Citrate
Current Status: 官方中间体目录（API: Ixazomib Citrate）
GMP Certification: —
CEP: No
DMF Type: —
Stability Data: —
BE Required: Not required / waivable
Registration Pathway: FSO 供货（非注册物质）
MOQ: 询价
Lead Time: 询价
Price Range: 询价

Registrable Markets

Global

Process / Sequence / Exact Price